Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215644
Status:
COMPLETED
Last Update Posted:
2018-11-02
First Post:
2005-09-15
Brief Title:
Matuzumab Treatment With Epirubicin Cisplatin and Capecitabine ECX in Esophago-Gastric Cancer
Sponsor:
Organization:
Merck KGaA Darmstadt Germany